Kinnari Patel - Aug 12, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
President & Chief Operating Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Kinnari Patel
Stock symbol
RCKT
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 05:31 PM
Previous filing
Feb 16, 2022
Next filing
Feb 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Restricted Stock Units Award $0 +52.5K $0.00 52.5K Aug 12, 2022 Common Stock 52.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units will become fully vested on August 12, 2025.

Remarks:

President & Chief Operating Officer